Company

Opus Genetics

Biotechnology Research Raleigh, Nc, United States 24 employees IRD

Employees: 24
Contacts: 4
Emails: 4
Phones: 4

www.opusgtx.com LinkedIn Crunchbase

Opus Genetics Overview

Headquarters: Raleigh, Nc, United States
Website: www.opusgtx.com
Industry: Biotechnology Research
Employees: 24
Stock Symbol: IRD
Funding: 2.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Gene Therapy and Rare Inherited Retinal Diseases

About Opus Genetics

Ocuphire Pharma, Inc. and Opus Genetics have combined under the Opus Genetics name (Nasdaq: IRD). As a combined company, we are committed to building an innovative, efficient and sustainable clinical-stage ophthalmic biopharmaceutical company leading the development of transformative gene therapies for the treatment of inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders.

Opus Genetics Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 4; 100.0% coverage

Opus Genetics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Nirav Jhaveri	Strategic Biotech CFO - Fundraising	New York, United States	Email Phone
Adrienne Graves	Independent Director, Public	San Francisco, California, United States	Email Phone
Joe Schachle	Chief Operating Officer at Opus Genetics	Raleigh, North Carolina, United States	Email Phone
Jay Pepose	Chief Medical Advisor @ Opus Genetics	Chesterfield, Missouri, United States	Email Phone